Search - tctmd.com

Displaying 201 - 220 of 318

Sort: Relevancy | Date

News Opinion Fellow Talk

Is Your Interventional Career the Scourge of Your Musculoskeletal System?

Mesfer Alfadhel, MD

July 18, 2018

News Daily News

No Harm Done: Foregoing Routine TEE and General Anesthesia in TAVR

Caitlin E. Cox

July 17, 2018

News Daily News

OCT, IVUS Each Boost Long-term Outcomes When Used to Guide PCI, Study Suggests

Todd Neale

July 16, 2018

News Daily News

Valve-in-Valve TAVR Meets ‘Benchmark’ Set by Native-Valve Cases for Safety, Effectiveness

Caitlin E. Cox

July 16, 2018

News Opinion Fellow Talk

Navigating Vascular Access as a Cardiology Fellow

Udit Bhatnagar, MD

July 12, 2018

News Daily News

New Review Probes Possibility of CVD Prevention Without Aspirin

Michael O'Riordan

July 04, 2018

News Daily News

‘Doomed’ by Genetics? Lifestyle Still Matters in Preventing CVD and Diabetes

Yael L. Maxwell

June 29, 2018

News Industry News

Essential Medical Announces Positive Results from The Safe Manta Clinical Trial, The First Pivotal Trial for a Dedicated Large Bore Closure Device

June 25, 2018

SAFE-MANTA: Large-Bore Vascular Closure Device Achieves Fast Hemostasis With Few Complications

Michael O'Riordan

June 23, 2018

Presentation The Structural Heart Disease Summit 2018

Early and Late PFO Closure Complications

Presenter: John D. Carroll, Brij Maini, Zahid Amin

June 23, 2018

Presentation The Structural Heart Disease Summit 2018

Procedural Complications of LAA Closure in Perspective: Frequency, Learning Curve, and More

Presenter: Robert J. Sommer, Brian K. Whisenant, Josep Rodés-Cabau

June 23, 2018

News Conference News The Structural Heart Disease Summit 2018

PORTICO I Postapproval Registry Outside the US Offers ‘Teaser’ for Pivotal Trial

Shelley Wood

June 23, 2018

News Conference News The Structural Heart Disease Summit 2018

High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense?

Michael O'Riordan

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Cases of Unusual Mechanisms of Coronary Occlusion During TAVR

Presenter: Omar Khalique

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

The New Syndrome of Delayed Coronary Occlusion (DCA) After TAVR: Frequency, Causes, and Outcomes

Presenter: Azeem Latib

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Incidence, Predictors, Consequences, Prevention, and Treatment of Coronary Occlusion During TAVR: Practical Clinical Guidelines

Presenter: Ariel Finkelstein

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Techniques to Reduce the Frequency of Pacemaker Implantation After TAVR

Presenter: Hemal Gada

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Incidence, Predictors, and Consequences of New LBBB and New Permanent Pacemakers After TAVR

Presenter: Tamim Nazif

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

When and How to Use Transcatheter Devices for PVL Closure After TAVR

Presenter: Colin M. Barker

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Expert Commentary: PVL Assessment and Management When to Postdilate

Presenter: Rebecca T. Hahn

June 21, 2018

Advertisement

Is Your Interventional Career the Scourge of Your Musculoskeletal System?

No Harm Done: Foregoing Routine TEE and General Anesthesia in TAVR

OCT, IVUS Each Boost Long-term Outcomes When Used to Guide PCI, Study Suggests

Valve-in-Valve TAVR Meets ‘Benchmark’ Set by Native-Valve Cases for Safety, Effectiveness

Navigating Vascular Access as a Cardiology Fellow

New Review Probes Possibility of CVD Prevention Without Aspirin

‘Doomed’ by Genetics? Lifestyle Still Matters in Preventing CVD and Diabetes

Essential Medical Announces Positive Results from The Safe Manta Clinical Trial, The First Pivotal Trial for a Dedicated Large Bore Closure Device

SAFE-MANTA: Large-Bore Vascular Closure Device Achieves Fast Hemostasis With Few Complications

Early and Late PFO Closure Complications

Procedural Complications of LAA Closure in Perspective: Frequency, Learning Curve, and More

PORTICO I Postapproval Registry Outside the US Offers ‘Teaser’ for Pivotal Trial

High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense?

Cases of Unusual Mechanisms of Coronary Occlusion During TAVR

The New Syndrome of Delayed Coronary Occlusion (DCA) After TAVR: Frequency, Causes, and Outcomes

Incidence, Predictors, Consequences, Prevention, and Treatment of Coronary Occlusion During TAVR: Practical Clinical Guidelines

Techniques to Reduce the Frequency of Pacemaker Implantation After TAVR

Incidence, Predictors, and Consequences of New LBBB and New Permanent Pacemakers After TAVR

When and How to Use Transcatheter Devices for PVL Closure After TAVR

Expert Commentary: PVL Assessment and Management When to Postdilate

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content